Cargando…
ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature
Ovarian cancer is the most deadly gynecological malignancy since most patients have metastatic disease at the time of diagnosis. Therefore, identification of critical pathways that contribute to ovarian cancer progression is necessary to yield novel therapeutic targets. Recently we reported that the...
Autores principales: | Roy, Lynn, Samyesudhas, Serene J., Carrasco, Martin, Li, Jun, Joseph, Stancy, Dahl, Richard, Dahl, Karen D. Cowden |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226688/ https://www.ncbi.nlm.nih.gov/pubmed/25327563 |
Ejemplares similares
-
ARID3B Induces Tumor Necrosis Factor Alpha Mediated Apoptosis While a Novel ARID3B Splice Form Does Not Induce Cell Death
por: Joseph, Stancy, et al.
Publicado: (2012) -
ARID3B Directly Regulates Ovarian Cancer Promoting Genes
por: Bobbs, Alexander, et al.
Publicado: (2015) -
Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018) -
Arid3b Is Critical for B Lymphocyte Development
por: Kurkewich, Jeffrey L., et al.
Publicado: (2016) -
MAPK Signaling Is Required for Generation of Tunneling Nanotube-Like Structures in Ovarian Cancer Cells
por: Cole, Jennifer M., et al.
Publicado: (2021)